Primary Care Closed Claims Experience of Massachusetts Malpractice Insurers
|
|
|
- Augusta Morris
- 10 years ago
- Views:
Transcription
1 Research Original Investigation Primary Care Closed Claims Experience of Massachusetts Malpractice Insurers Gordon D. Schiff, MD; Ann Louise Puopolo, RN, BSN; Anne Huben-Kearney, RN, BSN, MPA; Winnie Yu, MA, MBA; Carol Keohane, RN, BSN; Peggy McDonough, RN, BSN; Bonnie R. Ellis, RN, BSN; David W. Bates, MD; Madeleine Biondolillo, MD IMPORTANCE Despite prior focus on high-impact inpatient cases, there are increasing data and awareness that malpractice in the outpatient setting, particularly in primary care, is a leading contributor to malpractice risk and claims. Invited Commentary page 2069 Author Video Interview at jamainternalmedicine.com OBJECTIVE To study patterns of primary care malpractice types, causes, and outcomes as part of a Massachusetts ambulatory malpractice risk and safety improvement project. DESIGN, SETTING, AND PARTICIPANTS Retrospective review of pooled closed claims data of 2 malpractice carriers covering most Massachusetts physicians during a 5-year period (January 1, 2005, through December 31, 2009). Data were harmonized between the 2 insurers using a standardized taxonomy. Primary care practices in Massachusetts. All malpractice claims that involved primary care practices insured by the 2 largest insurers in the state were screened. A total of 551 claims from primary care practices were identified for the analysis. MAIN OUTCOMES AND MEASURES Numbers and types of claims, including whether claims involved primary care physicians or practices; classification of alleged malpractice (eg, misdiagnosis or medication error); patient diagnosis; breakdown in care process; and claim outcome (dismissed, settled, verdict for plaintiff, or verdict for defendant). RESULTS During a 5-year period there were 7224 malpractice claims of which 551 (7.7%) were from primary care practices. Allegations were related to diagnosis in 397 (72.1%), medications in 68 (12.3%), other medical treatment in 41 (7.4%), communication in 15 (2.7%), patient rights in 11 (2.0%), and patient safety or security in 8 (1.5%). Leading diagnoses were cancer (n = 190), heart diseases (n = 43), blood vessel diseases (n = 27), infections (n = 22), and stroke (n = 16). Primary care cases were significantly more likely to be settled (35.2% vs 20.5%) or result in a verdict for the plaintiff (1.6% vs 0.9%) compared with non general medical malpractice claims (P <.001). CONCLUSIONS AND RELEVANCE In Massachusetts, most primary care claims filed are related to alleged misdiagnosis. Compared with malpractice allegations in other settings, primary care ambulatory claims appear to be more difficult to defend, with more cases settled or resulting in a verdict for the plaintiff. JAMA Intern Med. 2013;173(22): doi: /jamainternmed Published online September 30, Author Affiliations: Author affiliations are listed at the end of this article. Corresponding Author: Gordon D. Schiff, MD, Center for Patient Safety Research and Practice, Harvard Medical School, Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital, 1620 Tremont St, Third Floor, Boston, MA ([email protected]). 2063
2 Research Original Investigation Primary Care Closed Claims The spotlight for improving patient safety and malpractice risk is increasingly focusing on outpatient care. 1-4 After several decades of relative neglect, outpatient safety issues, particularly in the primary care setting, are increasingly being recognized for both their magnitude and the risks that result from the increasing complexity of patients being treated in the outpatient setting, discontinuities, and increasing time and resource constraints. Many malpractice insurers now report that both the frequency and dollar amounts of outpatient claims exceed inpatient claims, with primary care offices and physicians frequently contributing to these outpatient claims. 5,6 Even simple outpatient processes, such as following up on a test result or making a referral, given the enormous volume and problem-prone logistics, are increasingly being identified as significant challenges that can create malpractice exposure. 5,7-9 Although much of the energy for malpractice reform in the United States has been expended on reform of the legal system, directing efforts upstream toward better understanding and preventing problems clearly represents a needed component of efforts to decrease malpractice litigation and patient harm Toward that end, the Agency for Healthcare Research and Quality has funded a series of projects, including one based in Massachusetts the Proactive Reduction of Outpatient Malpractice-Improving Safety, Efficiency, and Satisfaction (PROMISES) Project. 13 The PROMISES Project represents a collaboration of multiple stakeholders, including the Massachusetts Department of Public Health, leading Massachusetts academic and safety partners (Massachusetts Coalition for the Prevention of Medical Errors, Brigham and Women s Hospital, the Institute for Healthcare Improvement, and Harvard School of Public Health), and the state s 2 leading malpractice insurers The Risk Management Foundation of the Harvard Medical Institutions (Controlled Risk Insurance Company [CRICO]) and Coverys (formerly ProMutual Group), who together insure approximately 85% of the physicians in the state. As a part of this collaboration, the 2 insurers came together to share data from their malpractice cases. The aim was to identify practice and system issues found in malpractice cases to help inform the PROMISES Project improvement activities and to identify patient safety issues and interventions from which others could benefit. Although each insurer collects and analyzes its own litigation claims experience, we believed that pooling these data could give a broader statewide picture of the types of problems that lead to malpractice claims. In particular, we sought to examine the frequency, types of problems identified, problematic diagnoses, temporal trends, litigation outcomes, and priority areas for improvement that emerged from this aggregated statewide overview of claims experience. Methods Study Population The study population was all closed outpatient general medicine malpractice claims for practices and physicians insured by CRICO and Coverys for the most recent period for which complete closed claims data were available (January 1, 2005, through December 31, 2009). Data Collection Methods Databases from the 2 insurers were queried for all claims closed during the study period that involved adult primary care physicians, specifically, general internists, family practitioners, and practices, including nonurgent clinics, correctional facilities, and some long-term care. Cases were selected by the year closed and the presence of one or more general medicine physicians, whether or not an indemnity payment was made by the insurer. All patient-identifying information was removed using contextual deidentification, and records were merged into a common SAS database for analysis (SAS Institute Inc). To further protect anonymity of patients and insurers, records of which malpractice insurer contributed the case to the merged data set were deidentified. Because the 2 insurers used somewhat different classification systems to categorize the potential process of care breakdowns, we chose one insurer s (CRICO s) scheme and manually recoded the other insurer s data to produce a single classification scheme that identified where the alleged breakdowns in the processes of care occurred. The institutional review boards of the State of Massachusetts Department of Public Health and Brigham and Women s Hospital approved this study. Statistical Analysis For each of the 5 years studied, we performed descriptive statistics of the numbers of closed claims, patient diagnoses (deidentified), physician(s) named, disposition of case (eg, settled, verdict for plaintiff, or verdict for defendant), classification of breakdowns in the process of care (eg, diagnosis or medication), and subclass of breakdown (eg, for diagnosis: history or physical examination, evaluation of symptoms, ordering of tests, or test interpretation) based on the insurers review of the claim. When more than one breakdown occurred, multiple codes were assigned. Statistical t tests comparing outcomes of primary care vs non primary care cases were also performed using SAS statistical software (SAS Institute Inc). Results Pooling data from the 2 leading malpractice insurers closed claims in Massachusetts primary care settings alleging malpractice during the 5-year period 2005 through 2009 found a total of 551 claims. These 551 claims represent 7.7% of a total of 7224 cases (551 general medicine cases plus 6673 non general medicine inpatient and outpatient cases) closed for the 2 insurers from January 1, 2005, through December 31, During this period, the insurers covered a mean of 3305 general medical staff or fellow physicians; a mean of 110 cases were closed per year, for an overall rate of 3.3 cases per year per 100 physicians covered. A total of 595 physicians were named in these 551 cases: 525 were named in 1 case, 53 in 2 cases, and 17 in 3 or more cases. The 551 cases closed from January 1, 2005, through December 31, 2009, included cases in which the event occur JAMA Internal Medicine December 9/23, 2013 Volume 173, Number 22 jamainternalmedicine.com
3 Primary Care Closed Claims Original Investigation Research Table 1. Cases Closed by Allegation Type and Close Year No. of Cases Closed Allegation Type Total Diagnosis related Medication related Medical treatment Communication Violation of rights Safety and security Obstetrics-related treatment Surgical treatment Breach of confidentiality Total No. of Cases rence year of the alleged malpractice dated back as far as 1989, with most alleged malpractice occurrences being in the decade preceding the date of closing of the claim (averaging 3 years from filing to closing the claim). A total of 397 of 551 cases (72.1%) were diagnosis-related allegations, outnumbering medication-related and medical treatment related allegations by factors of 6:1 and 10:1, respectively (Table 1). The annual numbers and distributions of these claims categories were remarkably consistent during the 5-year period. Table 2 gives the final diagnoses for cases. Allegations regarding failure to diagnose or delay in diagnosis of cancer predominated, followed by failure or delay in diagnosis of diseases of the heart, blood vessels, infection, and cerebrovascular disease. Two-thirds of the cancer-related delayed diagnosis cases (129 of 190 [67.9%]) were 1 of 4 cancers colorectal, lung, prostate, and breast cancer. Each of these leading cancers had a somewhat different pattern and frequency of various breakdown points in the diagnostic process (Tables 3, 4, and 5). Issues in evaluation of symptoms and signs dominated breast cancer, whereas ordering and following up tests had a larger role in prostate cancer. Among the 56 cases of colorectal cancer with a diagnosis-related major allegation, 9 patients (16.1%) were 49 years or younger, with 3 (5.4%) being 39 years or younger (Table 5). The Figure illustrates the disposition of the closed cases, comparing differences between general medicine and non general medicine cases, as well as different outcomes in diagnosis cases vs medication-related cases. Although overall most claims were dropped, denied, dismissed, or received a verdict in favor of the defendant, we found significant differences in the rates of cases settled in general medicine cases vs non general medicine, particularly for those alleging diagnostic error. Ambulatory cases were significantly more likely to be settled (35.2% vs 20.5%) or result in a verdict for the plaintiff (1.6% vs 0.9%) compared with non general medical malpractice claims (P <.001). Because insurers often chose to settle cases that, on their experts reviews, they considered more difficult to defend, this significantly higher percentage suggests these cases might have had more obvious negligence, leading the malpractice insurer to negotiate a settlement with the plaintiff. Allegations of negligence in cases in which medicationrelated process issues were identified were much less frequent than diagnostic malpractice, but nevertheless drug treatment was the major issue in 68 cases. Considering the physician s role in ordering medications, only 11 cases (16.2% of the medication-related cases) had problems in the ordering stage, whereas 34 (50.0% of the medication cases) identified monitoring and administration as the problematic step in the medication use process. Discussion As part of a malpractice improvement collaborative project in Massachusetts, the state s 2 leading malpractice insurers pooled their primary care claims data to give an unprecedented look at statewide litigation experience. There were more than 100 such claims each year alleging malpractice in primary care offices, most of which are related to diagnostic errors, with cancer being the leading diagnosis alleged to be missed or delayed. Pooling data from 2 different types of insurers (not for profit vs for profit) covering different types of practices (largely academic vs private practices) and geographic areas (clustered around Boston vs distributed across the state) gave a more complete picture and illustrated the commonalities of these types of practices. Although the confidentiality agreement that permitted this data pooling collaborative precludes separate analyses and/or direct comparisons of the 2 insurers, the findings are comparable to what each has reported regarding their individual experiences. These findings include a substantial percentage of cases and settlement dollars arising in outpatient and primary care settings with a predominance of diagnosis errors data similar to those of other published studies. Compared with earlier studies, 5,6,14,15 diagnostic errors were even more common, with colorectal cancer replacing breast or other cancers as the most common alleged delayed cancer diagnosis. Both insurers conduct comprehensive physician practice risk evaluations and have found that the cases we document in our study also track closely with the types of process errors identified in such evaluations. jamainternalmedicine.com JAMA Internal Medicine December 9/23, 2013 Volume 173, Number
4 Research Original Investigation Primary Care Closed Claims Table 2. Cases Closed by Top Final Diagnoses and Top s No. of Cases Variable Closed Final diagnoses 190 Diseases of the heart 43 Diseases of blood vessels 27 Infection 22 Cerebrovascular disease 16 Lower gastrointestinal tract disorders 9 Orthopedic injuries 7 Pneumonia 6 Top cancers Colorectal 56 Lung 29 Prostate 26 Breast 18 Other gastrointestinal tract disorder 10 Benign neoplasm 8 Urinary organs 8 Lymphatic and hematopoietic tissue 8 Head and neck 6 Uterus and cervix 5 Adding weight and urgency to the need to address such issues was our finding that outpatient primary care in general and diagnostic cases in particular were more likely to be settled or result in a verdict for the plaintiff (Figure). This finding suggests that these cases may be harder to defend based on their malpractice insurers review of the case or that a court ruled in favor of allegations of substandard care, which occurred in 36.8% of the primary care diagnosis cases vs 21.4% of all other non general medicine cases (P <.001). Although we did not have access to other variables related to the settlement of these cases (ie, settlement decisionmaking factors unrelated to the actual medical care), this finding suggests there may be a higher rate of preventable adverse outcomes and/or identifiable failures to deliver an optimal standard of care in these cases. Although notable cases of wrong site surgery or lethal medication errors may capture the newspaper headlines, most primary care cases seem to be due to failures in more routine yet high-volume outpatient office processes. 16,17 Most failures were in diagnosis (mostly cancer) and can be pinpointed to just 3 broad areas of outpatient activity: (1) obtaining and regularly updating a comprehensive patient and family history, physical examination, and evaluation of symptoms; (2) ordering (or failure to order) diagnostic or laboratory tests; and (3) managing referrals and following up with the patient. It would appear that a finite number of safeguards could be put in place to prevent and/or mitigate these errors, which, in turn, could have a major effect on patient safety and malpractice. Testing such measures as (1) structured methods for reliably obtaining and updating patient or family history (including patient self-completed data) and physical examination records, (2) use of differential diagnosis reminders and checklists, and Table 3. Insurers Harmonized Taxonomy for Breakdowns in Process of Care Step Description 1 Patient notes problem and seeks care: access, scheduling, and/or waiting issues delayed patient seeking care for a recognized problem 2 History or physical examination and evaluation of symptoms: patient s history was not fully recorded or updated and/or an absent or inadequate physical examination 3 Order of diagnostic or laboratory tests: diagnostic or laboratory tests were not ordered or were delayed 4 Performance of tests: ordered test or laboratory tests were not performed or were delayed 5 Interpretation of test results: misinterpreted diagnostic studies or failed to rule out an abnormal finding 6 Receipt or transmittal of test results: test result was not received by the ordering physician or was not communicated to the patient 7 Physician follow-up with patient: lack of or failure in patient follow-up for education instruction, new finding, or routine screening or did not document follow-up efforts 8 Referral management: coordination of care involving referrals to specialties was not adequately managed or identification of the physician responsible for ongoing care was unclear 9 Patient adherence with follow-up plan: patient failed to adhere to the follow-up plan (3) implementation of more reliable test ordering and follow-up strategies, along with methods for ensuring specialty referral and follow-up and improved documentation in these 3 realms, offers avenues to address shortcomings found in these cases. 5,18,19 Optimally designing electronic medical records to more reliably and efficiently facilitate reengineering these functions and testing their effectiveness represents a priority for preventing future malpractice. The PROMISES Project has been testing various strategies, in part based on the insights from this overview of high-risk areas and processes in primary care. Our collaborative has emphasized a systematic practice-wide team approach aimed at 3+1 target areas for improving (1) test, (2) referral, and (3) medication management, plus overarching communication improvement strategies. Electronic health records can be powerful tools for ensuring that follow-up of some abnormal test results occurs. 8,20 However, the results of some tests, such as prostate-specific antigen, are much easier to track than others, such as nodules found incidentally on chest radiographs or new biopsy results that indicate malignant neoplasms, which may not be coded in ways that enable decision support. Furthermore, many electronic health records do not include robust tools that make it easy for physicians to ensure that important follow-up has occurred. Better approaches for all these areas and approaches that practices can use to ensure complete follow-up for key abnormalities, which may leverage but go beyond health information technology, will be valuable. 17,20-22 This study has several noteworthy and somewhat unexpected findings. One is the low percentage of diagnostic error cases related to receipt and transmittal of test results, which occurred in only 23 diagnostic error cases (5.8%). Experience had suggested that this is a particularly vulnerable step, especially because it is more readily identified retrospectively and thus more easily targeted for malpractice claims. 23,24 As noted previously, the relative scarcity of claims related to alleged errors in the medication ordering step, at least compared with issues in the medication monitoring stage, is also 2066 JAMA Internal Medicine December 9/23, 2013 Volume 173, Number 22 jamainternalmedicine.com
5 Primary Care Closed Claims Original Investigation Research Table 4. Breakdowns in the Process of Care for 4 Major s Cases, % Step of Care Process Breakdown All Diagnosis Cases (n = 397) Colorectal (n = 56) Lung (n = 29) Prostate (n = 26) Breast (n = 18) Patient notes problem and seeks care History or physical examination and evaluation of symptoms Order of diagnostic or laboratory tests Performance of tests Interpretation of tests Receipt or transmittal of test results Physician follow-up with patient Referral management Patient adherence with follow-up plan Table 5. Illustrative Patients From Primary Care Closed Claims Cases Case Summary A 28-year-old man presented to a PCP with intermittent rectal bleeding. Physical examination revealed no hemorrhoids, but the patient had a guaiac-positive stool sample. Fifteen subsequent office visits during the next 2 years without follow-up on this problem. The patient finally was referred to gastroenterologist 28 months from time of first PCP visit, and a diagnosis of rectal carcinoma was made. A 61-year-old man had a PSA of 5.95 at the time of first PCP visit. Eighteen months later, the PSA was 5.33 and no rectal examination was performed. Seven months later, the PSA was Physician s plan to recheck in 4-6 weeks, but family member who is physician made referral to urologist for biopsy. Diagnosis of prostate cancer with involvement of seminal vesicles. A 69-year-old woman had a family history (younger sister) of lung and colon cancer. At the initial visit, no documentation of stool guaiac or discussions of colorectal screening. Four months later, the patient presented with abdominal pain, guaiac-negative stool sample, and a normal hemoglobin level. Three subsequent visits for abdominal pain, treated with a histamine 2 -blocker, and for Helicobacter pylori. During the next 15 months, multiple appointments were scheduled and rescheduled by the patient with several missed appointments. Four months later, the patient had a visit for a tooth problem, 9 kg (20-lb) weight loss, and decreased hemoglobin level recorded but not addressed. Two months later, the patient presented to the emergency department with further weight loss and was found to have multiple pulmonary nodules and cecal mass with metastases to liver and lung. A 54-year-old woman with a 2-pack-per-day smoking history. Preoperative chest radiography ordered by the neurosurgeon before discectomy for a herniated disc noted a 2.5-cm new mass in the right lung; follow-up imaging was recommended by the radiologist in the report. Day surgery center nurse noted in medical record that patient s PCP was called with abnormal radiograph report, although both the PCP and surgeon denied receiving calls about the report. One year later, a chest radiograph ordered for right-side chest pain identified a 5-cm mass. Adenocarcinoma of the lung was diagnosed, and the patient died 1 year later of lung cancer. Breakdown or Delay in Steps in Care Process a Physical examination or evaluation Test result follow-up Follow-up Referral Physical examination or evaluation Test result interpretation Test result follow-up Follow-up Referral Physical examination or evaluation Test result follow-up Follow-up Referral Patient adherence Test result follow-up Abbreviations: PCP, primary care physician; PSA, prostate-specific antigen. a See Table 3 for operational definitions. a remarkable finding. 25 However, we suspect that many medication-related errors go undetected, and those that cause harm do not have sufficiently severe adverse outcomes to result in a malpractice claim. Figure. Disposition of Closed Cases Cases, % Dropped, denied, or dismissed Settled Plaintiff verdict Defense verdict 0 Diagnosis Cases (n = 397) Medication Cases (n = 68) All General Medicine Cases (n = 551) All Non General Medicine Cases (n = 6673) Comparison of the differences between general medicine and non general medicine cases and the different outcomes in diagnosis cases vs medication-related cases. There were 551 Risk Management Foundation of the Harvard Medical Institutions (Controlled Risk Insurance Company [CRICO]) and Coverys outpatient malpractice cases closed from 2005 through 2009 that named general medicine staff or fellow physicians (excluding hospitalists) and excluding emergency department locations. This analysis should be interpreted with several caveats and limitations. As noted above, retrospective closed malpractice claims reviews give only a partial picture of problems and safety risks, capturing what has often been called the tip of the iceberg. Closed malpractice claims overlook cases with process failures that have no, or less serious, adverse outcomes that are often undetected or do not lead a patient to file a claim. Our present study, although designed to give a comprehensive and representative picture of our entire state s experience, does not include a few self-insured practices and institutions. Furthermore, given the large number of academic institutions and affiliated practices in Massachusetts, ours may not be representative of other states nationally. The cases and trends are inherently not fully current with contemporary practices, given the lag period from the time a problem occurs and jamainternalmedicine.com JAMA Internal Medicine December 9/23, 2013 Volume 173, Number
6 Research Original Investigation Primary Care Closed Claims the filing of a malpractice claim, in addition to the time that elapses from the filing to the closing of claims (which was required for enrollment in our study). Because the taxonomy for classifying the cases differed somewhat between the 2 insurers, we had to map the cases to fit a unified schema. Because the data shared were not the detailed legal files but only limited case summaries, additional granular analysis of the cases was impossible, which limited more in-depth review of these cases. Thus, this high-level look does not permit an in-depth analysis of exactly how and why many of the errors occurred. A review of statewide malpractice claims experience for primary care physicians and practices revealed that such cases represent a substantial malpractice burden. Failure or delays in diagnosis, particularly for breast, lung, colorectal, and prostate cancers, represented the leading cases, each with its own patterns of problems. Targeting routine outpatient practice processes that create vulnerabilities to adverse patient outcomes and malpractice claims represents a priority for preventing these problems and lawsuits because, compared with other malpractice cases in other settings, they seem more difficult to defend. ARTICLE INFORMATION Accepted for Publication: July 26, Published Online: September 30, doi: /jamainternmed Author Affiliations: Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (Schiff, Bates); Center for Patient Safety Research and Practice, Division of General Internal Medicine and Primary Care, Department of Medicine, Harvard Medical School, Boston, Massachusetts (Schiff, Bates); The Risk Management Foundation of the Harvard Medical Institutions (Controlled Risk Insurance Company), Cambridge, Massachusetts (Puopolo, Yu, Keohane); CVS Caremark Corporation, Woonsocket, Rhode Island (Puopolo); Coverys Corporation, Boston, Massachusetts (Huben-Kearney, McDonough, Ellis); Signature Healthcare, Brockton, Massachusetts (Huben-Kearney); Massachusetts Department of Public Health, Boston (Biondolillo). Author Contributions: Mss Yu and McDonough had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Schiff, Puopolo, Keohane, Bates. Acquisition of data: Schiff, Puopolo, Yu, McDonough, Ellis. Analysis and interpretation of data: Schiff, Puopolo, Huben-Kearney, Yu, Keohane, McDonough, Ellis, Bates, Biondolillo. Drafting of the manuscript: Schiff, Puopolo, Huben-Kearney. Critical revision of the manuscript for important intellectual content: Schiff, Yu, Keohane, McDonough, Ellis, Bates, Biondolillo. Statistical analysis: Puopolo, Huben-Kearney, Yu, McDonough. Obtained funding: Schiff, Keohane. Administrative, technical, and material support: Schiff, Keohane, McDonough, Biondolillo. Study supervision: Schiff. Conflict of Interest Disclosures: None reported. Funding/Support: This study was supported by grant R18HS from the Agency for Healthcare Research and Quality. Role of the Sponsor: The insurers had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official vew of the Agency for Healthcare Research and Quality. Additional Contributions: The malpractice insurers shared their claims data, and Namara Brede, BA, provided administrative assistance in the final manuscript preparation. REFERENCES 1. Zuccotti G, Sato L. Malpractice risk in ambulatory settings: an increasing and underrecognized problem. JAMA. 2011;305(23): Wynia MK, Classen DC. Improving ambulatory patient safety: learning from the last decade, moving ahead in the next. JAMA. 2011;306(22): Gandhi TK, Lee TH. Patient safety beyond the hospital. N Engl J Med. 2010;363(11): Bishop TF, Ryan AM, Casalino LP. Paid malpractice claims for adverse events in inpatient and outpatient settings.jama. 2011;305(23): Gandhi TK, Kachalia A, Thomas EJ, et al. Missed and delayed diagnoses in the ambulatory setting. Ann Intern Med. 2006;145(7): Phillips RL Jr, Bartholomew LA, Dovey SM, Fryer GE Jr, Miyoshi TJ, Green LA. Learning from malpractice claims about negligent, adverse events in primary care in the United States. Qual Saf Health Care. 2004;13(2): Schiff G. Getting Results: Reliably Communicating and Acting on Critical Test Results. Oakbrook Terrace, IL: Joint Commission Resources; Schiff GD. Medical error: a 60-year-old man with delayed care for a renal mass. JAMA. 2011;305(18): Poon EG, Gandhi TK, Sequist TD, Murff HJ, Karson AS, Bates DW. I wish I had seen this test result earlier! : dissatisfaction with test result management systems in primary care. Arch Intern Med. 2004;164(20): Kachalia A, Mello MM. New directions in medical liability reform. N Engl J Med. 2011;364(16): Studdert DM, Mello MM, Brennan TA. Medical malpractice. N Engl J Med.2004;350(3): Studdert DM, Mello MM, Brennan TA. Defensive medicine and tort reform. J Gen Intern Med. 2010;25(5): HHS Announces Patient Safety and Medical Liability Demonstration Projects. June 11, Accessed January 20, Holohan TV, Colestro J, Grippi J, Converse J, Hughes M. Analysis of diagnostic error in paid malpractice claims with substandard care in a large healthcare system. South Med J. 2005;98(11): Tehrani ASS, Lee H, Mathews SC, et al. 25-Year summary of US malpractice claims for diagnostic errors [published online ahead of print April 22, 2013]. BMJ Qual Saf. 2013;22: doi: /bmjqs Sarkar U, Bonacum D, Strull W, et al. Challenges of making a diagnosis in the outpatient setting. BMJ Qual Saf. 2012;21(8): Singh H, Giardina TD, Meyer AN, Forjuoh SN, Reis MD, Thomas EJ. Types and origins of diagnostic errors in primary care settings. JAMA Intern Med. 2013;173(6): Schiff GD, Bates DW. Can electronic clinical documentation help prevent diagnostic errors? N Engl J Med. 2010;362(12): Poon EG, Kachalia A, Puopolo AL, Gandhi TK, Studdert DM. Cognitive errors and logistical breakdowns contributing to missed and delayed diagnoses of breast and colorectal cancers. J Gen Intern Med. 2012;27(11): Poon EG, Wang SJ, Gandhi TK, Bates DW, Kuperman GJ. Design and implementation of a comprehensive outpatient Results Manager. J Biomed Inform. 2003;36(1-2): Schiff GD. Eight questions for getting beyond getting results. Jt Comm J Qual Patient Saf. 2010;36(5): Weingart SN, Saadeh MG, Simchowitz B, et al. Process of care failures in breast cancer diagnosis. J Gen Intern Med. 2009;24(6): Casalino LP, Dunham D, Chin MH, et al. Frequency of failure to inform patients of clinically significant outpatient test results. Arch Intern Med. 2009;169(12): Poon EG, Haas JS, Louise Puopolo A, et al. Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med. 2004;19(4): Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW. Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Intern Med. 2002;162(21): JAMA Internal Medicine December 9/23, 2013 Volume 173, Number 22 jamainternalmedicine.com
The Accuracy of the Medical Malpractice System: What the Evidence Tells Us. Michelle Mello, JD, PhD Harvard School of Public Health
The Accuracy of the Medical Malpractice System: What the Evidence Tells Us Michelle Mello, JD, PhD Harvard School of Public Health 1 Today s discussion 1. The MIMEPS study 1. Methodology 2. Descriptive
PROF. M H CASSIMJEE HEAD OF DEPARTMENT OF FAMILY MEDICINE, P M BURG METROPOLITAN HOSPITAL COMPLEX & MIDLANDS REGION
PROF. M H CASSIMJEE HEAD OF DEPARTMENT OF FAMILY MEDICINE, P M BURG METROPOLITAN HOSPITAL COMPLEX & MIDLANDS REGION QUALITY IMPROVEMENT AND RISK MANAGEMENT Estimated that medical errors 8 th leading cause
Risk Management and Medical Liability
AAFP Reprint No. 281 Recommended Curriculum Guidelines for Family Medicine Residents Risk Management and Medical Liability This document was endorsed by the American Academy of Family Physicians (AAFP).
There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
MEDICAL MALPRACTICE FACT BOOK
MEDICAL MALPRACTICE FACT BOOK - 1 - Firm Profile For over a decade, The Law Offices of Bruce M. Robinson have been dedicated to protecting the rights of victims who have been injured by the negligent and
THE ANATOMY OF BETTER INTELLIGENCE
HARNESS DATA Utilize comparative and actionable claims benchmarking data to capture the deeply rooted drivers of risk, errors and expense. LEVERAGE ANALYTICS Learn critical signals to discern the most
Dentistry. Specialty Report. Group. MedPro Group Patient Safety & Risk Solutions. Berkshire Hathaway's dedicated healthcare liability solution
Dentistry Specialty Report April 2015 MedPro Group Patient Safety & Risk Solutions Group Berkshire Hathaway's dedicated healthcare liability solution MedPro Group is a member of the Berkshire Hathaway
The Emergency Department. Fear of Malpractice and Defensive Medicine in the Emergency Department. ED-Based Malpractice Claims
Fear of Malpractice and in the Emergency Department Darren P. Mareiniss, MD, JD Instructor Department of Emergency Medicine University of Maryland School of Medicine The Emergency Department Emergency
Today I will discuss medical negligence following a number of recent high profile cases and inquests.
Tipp FM Legal Slot 29 th May 2012 Medical Negligence John M. Lynch, Principal Today I will discuss medical negligence following a number of recent high profile cases and inquests. Firstly, what is Medical
ADVANCE DIRECTIVE VOLUME 19 SPRING 2010 PAGES 306-315. The Effect of Medical Malpractice. Jonathan Thomas *
ANNALS OF HEALTH LAW ADVANCE DIRECTIVE VOLUME 19 SPRING 2010 PAGES 306-315 The Effect of Medical Malpractice Jonathan Thomas * I. INTRODUCTION: WHAT IS MEDICAL MALPRACTICE Every year, medical malpractice
Prevention of Medical Errors
Prevention of Medical Errors FS 456.013(7) Florida Chapter of American College of Physicians St. Petersburg Beach, Florida October 5, 2013 Cliff Rapp, LHRM Regional Vice President Patient Safety Course
Medicare Advantage Risk Adjustment Data Validation CMS-HCC Pilot Study. Report to Medicare Advantage Organizations
Medicare Advantage Risk Adjustment Data Validation CMS-HCC Pilot Study Report to Medicare Advantage Organizations JULY 27, 2004 JULY 27, 2004 PAGE 1 Medicare Advantage Risk Adjustment Data Validation CMS-HCC
CNA and NSO Risk Control Self-assessment Checklist for Nurse Practitioners 1. Self-assessment topic Yes No Actions needed to reduce risks
Risk Control Self-assessment Checklist for Nurse Practitioners This checklist is designed to help nurse practitioners evaluate risk exposures associated with their current practice. For additional nurse
1. What is the prostate-specific antigen (PSA) test?
1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor
How To Improve Test Result Management
ORIGINAL INVESTIGATION I Wish I Had Seen This Test Result Earlier! Dissatisfaction With Test Result Management Systems in Primary Care Eric G. Poon, MD, MPH; Tejal K. Gandhi, MD, MPH; Thomas D. Sequist,
Do the Claims Hold Up? A Study of Medical Negligence Claims Against Neurologists
Journal of Empirical Legal Studies Volume 4, Issue 1, 155 162, March 2007 Do the Claims Hold Up? A Study of Medical Negligence Claims Against Neurologists Lee D. Cranberg, M.D., Thomas H. Glick, M.D.,
Medication error is the most common
Medication Reconciliation Transfer of medication information across settings keeping it free from error. By Jane H. Barnsteiner, PhD, RN, FAAN Medication error is the most common type of error affecting
Introduction to Medical Malpractice Insurance
William Gallagher Associates Introduction to Medical Malpractice Insurance What is Medical Malpractice Insurance? Insurance, in general, is the practice of sharing your risk with a large number of individuals
In the hospitalist model of care, after a patient leaves
Key Legal Principles for Hospitalists Ann Alpers, JD In a hospitalist system, when a patient leaves the hospital, he or she will return to a primary care provider (PCP) for follow-up and continuing care.
Medical Malpractice BAD DOCTORS. G. Randall Green, MD, JD St. Joseph s Hospital Health Center Syracuse, New York
Medical Malpractice BAD DOCTORS G. Randall Green, MD, JD St. Joseph s Hospital Health Center Syracuse, New York The nature of the crisis US not in a medical malpractice litigation crisis US in a medical
Background. Limitations
Safe Harbor Evaluation Planning Medical Liability and Patient Safety Planning Grant Agency for Health Research and Quality Grant Number 1R21HS019535 01 Background This evaluation planning was designed
Safe Transitions Best Practice Measures for
Safe Transitions Best Practice Measures for Hospitals Setting-specific process measures focused on cross-setting communication and patient activation, supporting safe patient care across the continuum
2011 Radiology Diagnosis Coding Update Questions and Answers
2011 Radiology Diagnosis Coding Update Questions and Answers How can we subscribe to the Coding Clinic for ICD-9 guidelines and updates? The American Hospital Association publishes this quarterly newsletter.
Medicare Part B. Mammograms - Updated Billing Guide for Screening and Diagnostic Tests
Mammograms - Updated Billing Guide for Screening and Diagnostic Tests This article from Medicare B News Issue 223 dated October 21, 2005 is being updated and reprinted to ensure that the Noridian Administrative
Update on SB3, The Georgia Tort Reform Law (Updated 3/22/2010)
Update on SB3, The Georgia Tort Reform Law (Updated 3/22/2010) Table of Contents: I. Damage Caps (O.C.G.A. 51-13-1) II. Joint and Several Liability (O.C.G.A. 51-12-31 and 51-12-33) III. Emergency Care
Malpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! Why this talk? Why me?
Malpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! G.R. Donowitz 2015 Why this talk? Why me? Expert witness for a long time Defense and Plaintiff work Have said, No, no case and
PSA screening in asymptomatic men the debate continues www.bpac.org.nz keyword: psa
PSA screening in asymptomatic men the debate continues www.bpac.org.nz keyword: psa Key messages: PSA is present in the benign and malignant prostate There is currently no national screening programme
What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide
What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide A M E R I C A N C O L L E G E O F C H E S T P H Y S I C I A N S Lung cancer is one of the most common cancers. About 170,000
Policy Research Perspectives
Policy Research Perspectives Medical Liability Claim Frequency: A 2007-2008 Snapshot of Physicians By Carol K. Kane, PhD Introduction This report presents a snapshot of physicians experiences with medical
LEGAL ISSUES IN WOUND CARE
LEGAL ISSUES IN WOUND CARE Contents Litigation.................................... 3 Standards of Care for Wound Care Practice.......... 3 Negligence................................... 4 Malpractice...................................
Missed and delayed diagnoses in the ambulatory setting
Annals of Internal Medicine Article Missed and Delayed Diagnoses in the Ambulatory Setting: A Study of Closed Malpractice Claims Tejal K. Gandhi, MD, MPH; Allen Kachalia, MD, JD; Eric J. Thomas, MD, MPH;
Early Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Personal Contact and Insurance Information
Kenneth A. Holt, M.D. 3320 Executive Drive Tele: 919-877-1100 Building E, Suite 222 Fax: 919-877-8118 Raleigh, NC 27609 Personal Contact and Insurance Information Please fill out this form as completely
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS. foundationforwomenscancer.org
Understanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS foundationforwomenscancer.org Contents Introduction...1 CA 125................................... 1 The CA 125 Test...2 The Use of the CA
THE CLEVELAND CLINIC. personal. Health. Management. Program
THE CLEVELAND CLINIC personal Health Management Program Our Personal Health Management Program offers a comprehensive examination in a package tailored to meet your unique medical needs. Expert Care The
Having a Breast Biopsy. A Guide for Women and Their Families
Having a Breast Biopsy A Guide for Women and Their Families Fast Facts n n Most women who have a breast biopsy do not have breast cancer. About 4 out of every 5 breast biopsies are negative for cancer.
Prostate Cancer Screening. A Decision Guide
Prostate Cancer Screening A Decision Guide This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Is screening right for you?
Question and Answer Submissions
AACE Endocrine Coding Webinar Welcome to the Brave New World: Billing for Endocrine E & M Services in 2010 Question and Answer Submissions Q: If a patient returns after a year or so and takes excessive
Provincial Quality Management Programs for Mammography, Colonoscopy and Pathology in Ontario
Provincial Quality Management Programs for Mammography, Colonoscopy and Pathology in Ontario Quality Management Partnership Consultation Materials: Heal th System Ad mi nistrato r s October 20, 2014 Table
Mitigating Surgical Medical Malpractice Exposure in Ambulatory Surgery Centers
Mitigating Surgical Medical Malpractice Exposure in Ambulatory Surgery Centers Making Your Ambulatory Surgery Center a Healthcare SafetyZone Even though Ambulatory Surgery Centers (ASCs) have been around
WILL EQUITY BE ACHIEVED THROUGH HEALTH CARE REFORM? John Z. Ayanian, MD, MPP
WILL EQUITY BE ACHIEVED THROUGH HEALTH CARE REFORM? John Z. Ayanian, MD, MPP Brigham and Women s Hospital Harvard Medical School Harvard School of Public Health BWH Patient-Centered Outcomes Seminar April
Playing it safe: Hints to avoid a claim Presentation to University of Melbourne Students
Playing it safe: Hints to avoid a claim Presentation to University of Melbourne Students Disclaimer: The information in this presentation is general information relating to legal and/or clinical issues
Prostate Cancer Screening in Taiwan: a must
Prostate Cancer Screening in Taiwan: a must 吳 俊 德 基 隆 長 庚 醫 院 台 灣 醫 學 會 105 th What is the PSA test? The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally
Attorney s Truths MAMMOGRAPHY AND MALPRACTICE
Attorney s Truths MAMMOGAPHY AND MALPACTICE Advocates in an adversarial system epresents clients zealously Seek only facts that support their clients or positions Ignore or discard facts that do not Mammographersand
Guidelines for using V-CODES (Status Codes)
1 Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur without the permission of Tulane University.
SPECIFIC DATA FIELD INSTRUCTIONS
SPECIFIC DATA FIELD INSTRUCTIONS NAIC NUMBER: Enter the five-digit numeric company code supplied by the National Association of Insurance Commissioners. A convenient source is page 1 of the company statutory
Supplemental Technical Information
An Introductory Analysis of Potentially Preventable Health Care Events in Minnesota Overview Supplemental Technical Information This document provides additional technical information on the 3M Health
NURSE PRACTITIONER CLAIMS STUDY. An Analysis of Claims with Risk Management Recommendations
NURSE PRACTITIONER CLAIMS STUDY An Analysis of Claims with Risk Management Recommendations 1994-2004 As the clinical role of the nurse practitioner expands, it is essential to incorporate effective risk
A CONSUMER'S GUIDE TO CANCER INSURANCE. from YOUR North Carolina Department of Insurance CONSUMER'SGUIDE
A CONSUMER'S GUIDE TO from YOUR North Carolina Department of Insurance CONSUMER'SGUIDE IMPORTANT INFORMATION WHAT IS? Cancer insurance provides benefits only if you are diagnosed with cancer, as defined
Technical Assistance Document 5
Technical Assistance Document 5 Information Sharing with Family Members of Adult Behavioral Health Recipients Developed by the Arizona Department of Health Services Division of Behavioral Health Services
Physician and other health professional services
O n l i n e A p p e n d i x e s 4 Physician and other health professional services 4-A O n l i n e A p p e n d i x Access to physician and other health professional services 4 a1 Access to physician care
Clinical Trials and Screening: What You Need to Know
Scan for mobile link. Clinical Trials and Screening: What You Need to Know What is a Clinical Trial? At A Glance A clinical trial is a research study that tests how well new medical techniques work in
It s important to understand the process and react properly when it occurs.
Doctor, You ve Been Sued! It s important to understand the process and react properly when it occurs. By Howard S. Rosenbaum, DPM Malpractice suits are terrifying events for most podiatric physicians.
Testimony Before: Senate Codes, Health & Insurance Committees. 10:00 a.m. Hearing Room B, Legislative Office Building Albany, NY
Testimony Before: Senate Codes, Health & Insurance Committees Tuesday, December 1, 2009 10:00 a.m. Hearing Room B, Legislative Office Building Albany, NY Presented By: Dr. William Doscher, MD, FACS Legislative
BREAKING THE CODE IN MEDICAL NEGLIGENCE CASES
BREAKING THE CODE IN MEDICAL NEGLIGENCE CASES ALEXANDER B. KLEIN, III The Klein Law Firm 2000 The Lyric Centre 440 Louisiana Street Houston, Texas 77002 Telephone: (713) 650-1111 Toll Free: (800) 818-1601
Guide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
!"#$%&%'()&*+'"(,+"''*-*.
/0'"0-'1!"#$%&%'()&*+'"(,+"''*-*.!"#$%&%'()&*)'"(+$(%,'($')#*-(.'&-+*/()&0$'(#1()&*)'"2"'.&%'-(-'&%,(+*(3'*(&*-(&4#0%(56(7'")'*%(#1(&..( -+&/*#$'-(7"#$%&%'()&*)'"$(&"'(1#0*-(+*(3'*(&/'(58(#"(#.-'"9 : (;'-+)&"'(7"#
Newsletter Medical Negligence Issue 2004
Newsletter Medical Negligence Issue 2004 OPENING REMARKS Injury and wrongful death claims resulting from medical negligence make up a significant part of our practice. Many of these cases involve complex
An Enterprise Risk Management Approach to Consent to Treatment
An Enterprise Risk Management Approach to Consent to Treatment Fay A. Rozovsky, JD, MPH The Rozovsky Group, Inc., Bloomfield, CT Timothy Kelly, MS, MBA Dialog Medical, Atlanta, GA AGENDA Discuss the historic
Highlights of the Revised Official ICD-9-CM Guidelines for Coding and Reporting Effective October 1, 2008
Highlights of the Revised Official ICD-9-CM Guidelines for Coding and Reporting Effective October 1, 2008 Please refer to the complete ICD-9-CM Official Guidelines for Coding and Reporting posted on this
Title 19, Part 3, Chapter 14: Managed Care Plan Network Adequacy. Requirements for Health Carriers and Participating Providers
Title 19, Part 3, Chapter 14: Managed Care Plan Network Adequacy Table of Contents Rule 14.01. Rule 14.02. Rule 14.03. Rule 14.04. Rule 14.05. Rule 14.06. Rule 14.07. Rule 14.08. Rule 14.09. Rule 14.10.
PSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?
Cancer in Primary Care: Prostate Cancer Screening How and How often? Should we and in which patients? PLCO trial (Prostate, Lung, Colorectal and Ovarian) Results In the screening group, rates of compliance
Ten Strategies for Successfully Resolving a Medical Malpractice Claim
This article was prepared or accomplished by the contributing author in his/her personal capacity. The opinions and positions expressed in this article are the author's own and do not necessarily reflect
Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease
International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed
CHAPTER 21 Error in medical practice
CHAPTER 21 Error in medical practice Steven Lillis is a general practitioner in Hamilton, and Medical Adviser for the Medical Council. Cite this as Lillis S 2013. Error in medical practice. Chapter 21
MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850
LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock
MEDICARE PHYSICAL THERAPY. Self-Referring Providers Generally Referred More Beneficiaries but Fewer Services per Beneficiary
United States Government Accountability Office Report to Congressional Requesters April 2014 MEDICARE PHYSICAL THERAPY Self-Referring Providers Generally Referred More Beneficiaries but Fewer Services
Adoption of Information Technology in Healthcare: Benefits & Constraints
Adoption of Information Technology in Healthcare: Benefits & Constraints A WiredFox Technologies White Paper 2 Adoption of Information Technology in Healthcare: Benefits & Constraints By Jeff Yelton 3
Official reprint from UpToDate www.uptodate.com 2013 UpToDate
Official reprint from UpToDate www.uptodate.com 2013 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek
KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY. Always Here When You Need Us
KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY Always Here When You Need Us Kings County Hospital Center Cancer Care Program ANNUAL REPORT 2013: EXECUTIVE SUMMARY The Kings County Hospital Center Cancer
William J. Leedom Shareholder Phone: 206.622.5511 Email: [email protected]
I William J. Leedom Shareholder Phone: 206.622.5511 Email: [email protected] Bill is a distinguished trial lawyer. Over the past forty years, he has represented clients in over 80 jury trials in the state
990 Clock Hours 91 Quarter Credits
Medical BILLING ADMINISTRATIVE SPECIALISTS PROGRAM 990 Clock Hours 91 Quarter Credits Course # CouRSE clock Hours Credits MBAS101 Introduction to Medical Administrative Duties 40 4.0 MBAS103 Medical Terminology
The Lewin Group undertook the following steps to identify the guidelines relevant to the 11 targeted procedures:
Guidelines The following is a list of proposed medical specialty guidelines that have been found for the 11 targeted procedures to be included in the Medicare Imaging Demonstration. The list includes only
An Introduction to PROSTATE CANCER
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
Stakeholder Guide 2014 www.effectivehealthcare.ahrq.gov
Stakeholder Guide 2014 www.effectivehealthcare.ahrq.gov AHRQ Publication No. 14-EHC010-EF Replaces Publication No. 11-EHC069-EF February 2014 Effective Health Care Program Stakeholder Guide Contents Introduction...1
